In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study

P Vandenberghe1, J Delabie, M de Boer

  • 1Department of Internal Medicine and Pathophysiology, University of Leuven, Belgium.

Insights

The B7/BB1 molecule, a T cell co-stimulatory ligand, is expressed on various immune cells, including dendritic cells and B cells. Its presence in fetal thymus suggests a role in thymocyte development.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • B7/BB1 is a key ligand for CD28, a T lymphocyte receptor involved in immune responses.
  • CD28 ligation by B7/BB1 enhances cytokine production and prevents T cell anergy.
  • Previous studies indicated B7/BB1 expression on dendritic cells, activated B cells, and monocytes.

Purpose of the Study:

  • To investigate the in situ expression and tissue distribution of B7/BB1.
  • To elucidate the role of B7/BB1 in T cell activation and thymocyte maturation.

Main Methods:

  • Immunohistochemistry using a novel monoclonal antibody (mAb B7-24).
  • Analysis of tissue samples including skin, lymph nodes, spleen, and thymus.

Main Results:

  • Strong B7/BB1 expression was observed on dendritic cells in various tissues (Langerhans cells, veiled cells, interdigitating dendritic cells).
  • B7/BB1 was present on fetal thymus dendritic cells but absent in adult thymuses.
  • Expression was also noted on a subset of B immunoblasts and germinal center B cells, and on macrophages/epithelioid cells in granulomatous inflammation.

Conclusions:

  • Tissue distribution of B7/BB1 supports its co-stimulatory role in T cell activation in vivo, particularly on professional antigen-presenting cells.
  • The presence of B7/BB1 in the fetal thymic medulla suggests a role in thymocyte development and maturation.